These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9427782)

  • 61. Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.
    Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM
    Aust N Z J Public Health; 2015 Oct; 39(5):434-40. PubMed ID: 26437728
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tamoxifen and endometrial cancer.
    Thylan S
    J Reprod Med; 1996 Nov; 41(11):830-1. PubMed ID: 8951133
    [No Abstract]   [Full Text] [Related]  

  • 63. Endometrial cancer and hormone replacement therapy - where does the risk lie?
    Future Oncol; 2005 Jun; 1(3):293. PubMed ID: 16556001
    [No Abstract]   [Full Text] [Related]  

  • 64. Combined continuous hormone replacement therapy: a critical review.
    Gambrell RD
    Obstet Gynecol; 1995 Nov; 86(5):869-70. PubMed ID: 7566870
    [No Abstract]   [Full Text] [Related]  

  • 65. Hormone replacement therapy and malignancy.
    Fitzgerald CT; Elstein M; Mansel RE
    Br J Obstet Gynaecol; 1993 May; 100(5):408-10. PubMed ID: 8518237
    [No Abstract]   [Full Text] [Related]  

  • 66. [Female genital cancer and life style factors. New discoveries in epidemiological front-line research].
    Wilhelmson B
    Lakartidningen; 1995 Mar; 92(12):1248-55. PubMed ID: 7707768
    [No Abstract]   [Full Text] [Related]  

  • 67. [Endocrine system. a. Hormone replacement therapy--improvement of in bone metabolism and cancer risk of long term therapy].
    Ota H
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Aug; 46(8):749-63. PubMed ID: 8089612
    [No Abstract]   [Full Text] [Related]  

  • 68. Neoplasia of the female reproductive tract: effects of hormone therapy.
    Archer DF
    Endocrine; 2004 Aug; 24(3):259-63. PubMed ID: 15542895
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Hormone replacement therapy and ovarian tumors].
    Sevcík L; Klát J; Koliba P
    Ceska Gynekol; 2002 Mar; 67(2):55-8. PubMed ID: 11987569
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hormone replacement therapy after endometrial cancer.
    Manley K; Edey K; Braybrooke J; Murdoch J
    Menopause Int; 2012 Dec; 18(4):134-8. PubMed ID: 23146818
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hormone replacement therapy after cancers.
    Creasman WT
    Curr Opin Oncol; 2005 Sep; 17(5):493-9. PubMed ID: 16093802
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Wanted: more evidence on whether estrogen replacement causes cancer.
    Naftolin F; Rutherford TJ; Chambers JT; Carcangiu ML
    J Soc Gynecol Investig; 1997; 4(2):57. PubMed ID: 9101461
    [No Abstract]   [Full Text] [Related]  

  • 73. Hormone replacement therapy and cancer.
    Mack TM
    Baillieres Clin Endocrinol Metab; 1993 Jan; 7(1):113-49. PubMed ID: 8435049
    [No Abstract]   [Full Text] [Related]  

  • 74. Case-control study of oestrogen replacement therapy and risk of cervical cancer.
    Parazzini F; La Vecchia C; Negri E; Franceschi S; Moroni S; Chatenoud L; Bolis G
    BMJ; 1997 Jul; 315(7100):85-8. PubMed ID: 9240046
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Menopausal hormonal therapy and cancer risks].
    Lasserre A; Fournier A
    Gynecol Obstet Fertil; 2016; 44(7-8):424-7. PubMed ID: 27451070
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Estrogen use and cancer incidence: a review.
    Lupulescu A
    Cancer Invest; 1995; 13(3):287-95. PubMed ID: 7743382
    [No Abstract]   [Full Text] [Related]  

  • 77. [Endometrial carcinoma during estrogen replacement therapy in spite of addition of progestagens].
    Meuwissen JH; Klinkhamer PJ; Brölmann HA; Wiegerinck MA
    Ned Tijdschr Geneeskd; 1993 Jul; 137(29):1473. PubMed ID: 8361563
    [No Abstract]   [Full Text] [Related]  

  • 78. Endocrine Treatment and Prevention of Breast and Gynecological Cancers Vth International Symposium of the Flemish Gynecological Oncology Group, January 26-28, 2006.
    Neven P; Vergote I; Amant F; Berteloot P; de Jonge E; DE Rop C; DE Sutter P; Makar A; VAN Ginderachter J
    Int J Gynecol Cancer; 2006; 16 Suppl 2():479-91. PubMed ID: 17010051
    [No Abstract]   [Full Text] [Related]  

  • 79. Hormone replacement therapy and female malignancy: what has the Million Women Study added to our knowledge?
    Marsden J
    J Fam Plann Reprod Health Care; 2007 Oct; 33(4):237-43. PubMed ID: 17925102
    [No Abstract]   [Full Text] [Related]  

  • 80. [Clinico-experimental study of using plant preparations from the flowers of Filipendula ulmaria (L.) Maxim for the treatment of precancerous changes and prevention of uterine cervical cancer].
    Peresun'ko AP; Bespalov VG; Limarenko AI; Aleksandrov VA
    Vopr Onkol; 1993; 39(7-12):291-5. PubMed ID: 7825300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.